Webcast: Pills and CEOs Under Fire as M&A Fades
The Deal and its expert panel discuss increased scrutiny on executive pay, poison pills and other measures taken to defend against activist campaigns.
Restructuring
Precedent-setting perspective on current bankruptcy and restructuring situations, plus weekly takes on companies that will likely be in need of advisory assistance.
Restructuring Intelligence
News From The Deal
Drinks With The Deal: Dechert's Ken Young
Dechert's Ken Young discusses how PE firms have diversified, the challenges of partner development and his recent deals.
Webcast: SPACs are Back
The Deal and its panel of experts discuss the proliferation of SPACs in the IPO market and whether this trend will continue as the economy rebounds.
